Mutual of America Capital Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-70,792
Closed -$1.52M 1634
2022
Q2
$1.52M Sell
70,792
-529
-0.7% -$14.7K 0.02% 970
2022
Q1
$2.64M Sell
71,321
-3,100
-4% -$121K 0.03% 840
2021
Q4
$3.38M Buy
74,421
+14,025
+23% +$732K 0.03% 762
2021
Q3
$3.83M Sell
60,396
-871
-1% -$66.3K 0.04% 673
2021
Q2
$5.61M Sell
61,267
-2,644
-4% -$210K 0.06% 466
2021
Q1
$4.35M Sell
63,911
-3,519
-5% -$273K 0.05% 596
2020
Q4
$4.88M Sell
67,430
-1,388
-2% -$80.4K 0.06% 461
2020
Q3
$2.61M Sell
68,818
-11,839
-15% -$400K 0.03% 689
2020
Q2
$2.86M Buy
80,657
+19,756
+32% +$562K 0.04% 639
2020
Q1
$1.33M Sell
60,901
-2,678
-4% -$60K 0.02% 886
2019
Q4
$1.37M Sell
63,579
-444
-0.7% -$10.2K 0.02% 1037
2019
Q3
$1.45M Sell
64,023
-1,263
-2% -$35K 0.02% 985
2019
Q2
$2.35M Buy
65,286
+42
+0.1% +$1.34K 0.03% 809
2019
Q1
$2.06M Buy
+65,244
New +$1.9M 0.03% 851

Other funds holding CDNA

Mutual of America Capital Management's CDNA Position: Q3 2022 in Review

Mutual of America Capital Management sold out of CareDx (CDNA) in Q3 2022, closing a stake of 70,792 shares — an estimated $1.52M sold.

Mutual of America Capital Management first reported a position in CDNA in Q1 2019 and held it in 14 quarters. The position peaked at $5.61M in Q2 2021. 182 funds tracked by Wall St. Rank hold CDNA as of Q3 2022.

  • Mutual of America Capital Management reported no remaining CareDx position as of Q3 2022 after selling out during the quarter.
  • Mutual of America Capital Management sold 70,792 CareDx shares in Q3 2022, an estimated $1.52M.
  • Mutual of America Capital Management first reported a position in CareDx in Q1 2019 and held it in 14 quarters.
  • Mutual of America Capital Management's CareDx position peaked at $5.61M in Q2 2021.
  • 182 funds tracked by Wall St. Rank held CareDx as of Q3 2022.

Based on Mutual of America Capital Management's 13F filing for Q3 2022, filed 8 Nov 2022.